- Home
- KROS vs MLKN Comparison
KROS vs MLKN Comparison
Compare KROS & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- MLKN
- Stock Information
- Founded
- KROS 2015
- MLKN 1905
- Country
- KROS United States
- MLKN United States
- Employees
- KROS N/A
- MLKN N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- MLKN Office Equipment/Supplies/Services
- Sector
- KROS Health Care
- MLKN Consumer Discretionary
- Exchange
- KROS Nasdaq
- MLKN Nasdaq
- Market Cap
- KROS 1.8B
- MLKN 1.7B
- IPO Year
- KROS 2020
- MLKN N/A
- Fundamental
- Price
- KROS $56.62
- MLKN $24.07
- Analyst Decision
- KROS Strong Buy
- MLKN
- Analyst Count
- KROS 8
- MLKN 0
- Target Price
- KROS $91.43
- MLKN N/A
- AVG Volume (30 Days)
- KROS 383.1K
- MLKN 515.1K
- Earning Date
- KROS 11-06-2024
- MLKN 12-18-2024
- Dividend Yield
- KROS N/A
- MLKN 3.14%
- EPS Growth
- KROS N/A
- MLKN 105.74
- EPS
- KROS N/A
- MLKN 0.88
- Revenue
- KROS $651,000.00
- MLKN $3,572,200,000.00
- Revenue This Year
- KROS $1,232.45
- MLKN $4.04
- Revenue Next Year
- KROS $126.39
- MLKN $4.16
- P/E Ratio
- KROS N/A
- MLKN $27.07
- Revenue Growth
- KROS 8037.50
- MLKN N/A
- 52 Week Low
- KROS $27.31
- MLKN $22.35
- 52 Week High
- KROS $73.00
- MLKN $31.73
- Technical
- Relative Strength Index (RSI)
- KROS 38.94
- MLKN 51.67
- Support Level
- KROS $65.54
- MLKN $23.84
- Resistance Level
- KROS $70.26
- MLKN $25.05
- Average True Range (ATR)
- KROS 3.17
- MLKN 0.59
- MACD
- KROS -0.64
- MLKN 0.17
- Stochastic Oscillator
- KROS 9.07
- MLKN 73.82
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.